Yervoy is First Melanoma Drug to Get FDA Approval in 13 Years

by Kathy Jones on  March 26, 2011 at 5:56 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

Bristol-Myers Squibb Co's skin cancer drug, Yervoy, has been given approval by the US Food and Drug Administration, becoming the first melanoma drug to gain an approval in 13 years.
 Yervoy is First Melanoma Drug to Get FDA Approval in 13 Years
Yervoy is First Melanoma Drug to Get FDA Approval in 13 Years

The Injectable ipilimumab drug has been hailed as the best drug available in the market to prolong the lives of those suffering from the deadly skin disease. So far the FDA has only given its approval to two drugs for the disease though none of them have proved to be very effective.

The drug blocks off a molecule known as CTLA-4 which is key to melanoma since it interferes with the activity of white blood cells. However when the molecule is blocked, then the WBCs continue their fight against the cancer cells.

Expressing his happiness over the approval for the drug, Melanoma Research Foundation's Tim Turnham said, "Clearly this is not a home run, but it's a solid base hit. And because we see other things in the pipeline, we think this the first in a series of important new therapies for melanoma."


Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Skin Cancer Ultra-Violet Radiation Signature Drug Toxicity Melanoma 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive